Engineered UstD Biocatalysts for Gamma-Hydroxy Amino Acid Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of non-standard amino acids (nsAAs) is often a time-consuming and tedious process involving multiple chemical transformations and purifications, and traditional synthetic chemistry struggles with highly specialized enzyme-mediated transformations required for biosynthetic pathways of natural products.

Innovation Solution

Utilizing a mutated UstD enzyme, which is at least 50% identical to the wild-type UstD enzyme, to catalyze the conversion of aldehyde-bearing molecules into gamma-hydroxy amino acids by contacting an aldehyde-containing substrate and an amino acid under specific conditions, including the presence of pyridoxal 5′-phosphate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional synthetic chemistry is used to synthesize non-standard amino acids, then multiple chemical transformations and purifications are required, but the process becomes time-consuming and tedious

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidsynthesis time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent replaces traditional chemical synthesis methods with enzymatic catalysis using engineered UstD enzymes. The enzyme-catalyzed reaction directly converts L-aspartate and aldehydes into gamma-hydroxy amino acids in a single step, eliminating the need for multiple chemical transformations and purifications required in conventional synthetic chemistry, thus dramatically reducing synthesis time and improving efficiency

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs directed evolution to modify specific parameters of the UstD enzyme (amino acid sequence, catalytic activity, substrate specificity) to optimize the reaction conditions. By changing enzymatic parameters through mutagenesis, the system achieves high productivity and selectivity in gamma-hydroxy amino acid synthesis, overcoming the limitations of traditional chemical methods

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If highly specialized enzymes are used to carry out chemo-, stereo-, and regioselective transformations in biosynthetic pathways, then complex natural products can be synthesized, but traditional synthetic chemistry struggles to accomplish these transformations

Engineering Contradiction:
ImproveselectivityVSAvoidsynthesis feasibility
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent uses engineered UstD enzymes to perform highly selective chemo-, stereo-, and regioselective transformations that are difficult or impossible to achieve with traditional chemical methods. The enzyme's active site is designed to recognize specific substrates and catalyze formation of gamma-hydroxy amino acids with precise stereochemistry, replacing complex multi-step chemical syntheses with a single enzymatic reaction

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates a universal enzymatic system that can synthesize multiple different gamma-hydroxy amino acids using the same enzyme framework and reaction type. By modifying substrate structure rather than enzyme structure, the system achieves versatility in producing various nsAAs with different side chains, simplifying the synthesis of diverse compounds

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If wild-type UstD enzyme is used to catalyze the conversion of aldehyde-bearing molecules into gamma-hydroxy amino acids, then the reaction proceeds, but the catalytic activity and turnover number are limited

Engineering Contradiction:
Improveturnover numberVSAvoidcatalytic efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies directed evolution to modify specific amino acid residues in the UstD enzyme sequence, changing catalytic parameters to enhance substrate binding, transition state stabilization, and product release. These parameter changes result in engineered enzymes with turnover numbers up to 7.7-fold higher than wild-type, while maintaining high selectivity for the desired reaction

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs iterative screening and selection processes where enzyme variants are tested for catalytic activity, and the most active variants are selected for further engineering. This feedback loop continues until optimal enzyme performance is achieved, systematically improving turnover number and catalytic efficiency based on measured reaction rates

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method enables the efficient production of a variety of gamma-hydroxy amino acids with high diastereoselectivity and improved catalytic activity, achieving turnover numbers up to 7.7-fold higher than wild-type UstD.

Implementation Method 1

The method comprises contacting an aldehyde-containing substrate, an amino acid, and an unnatural, mutated UstD enzyme... to yield a gamma-hydroxy amino acid product

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

The final step of the biosynthetic pathway involves a pyridoxal 5′-phosphate (PLP)-dependent enzyme: UstD. This enzyme catalyzes the decarboxylation of L-aspartate to form a nucleophilic enamine intermediate

Methodology Applied
Scientific EffectPyridoxal 5'-phosphate (PLP) coenzyme mechanism: Catalysis

Data Source

PatentUS20250223619A1Engineered biocatalysts for the synthesis of gamma-hydroxy amino acids
Publication Date: 2025.07.10 WISCONSIN ALUMNI RES FOUND
  • US20250223619A1 patent drawing
  • US20250223619A1 patent drawing
  • US20250223619A1 patent drawing

AI summary

A DNA expression construct comprising a polynucleotide encoding an unnatural UstD enzyme, the unnatural enzyme itself, and a method of making gamma-hydroxy amino acids by contacting an aldehyde-containing substrate, an amino acid, and the unnatural, purified UstD enzyme under conditions and for a time sufficient to react at least a portion of the aldehyde-containing substrate with at least a portion of the amino acid, to yield a gamma-hydroxy amino acid product.